Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor–positive, HER2-negative, untreated early breast cancer (ER+/HER2– ...
Slay the Spire 2 may still be in early access, but wow... It's already incredible. Here's our preview of the game so far.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results